Commentary Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.46439/pediatrics.4.027
Evaluation of chronic pediatric diarrhea: use of newer imaging tools – a more practical approach
Atul Kapoor1,*
- 1Advanced Diagnostics and Institute of Imaging, Amritsar, India
Corresponding Author
Atul Kapoor, masatulak@aim.com
Received Date: February 18, 2024
Accepted Date: April 05, 2024
Kapoor A. Evaluation of chronic pediatric diarrhea: use of newer imaging tools – a more practical approach. Clin Pediatr Neonatol. 2024;4(1):22-24.
Copyright: © 2024 Kapoor A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
A comparison of endoscopic ultrasoundguided fine needle aspiration and fine needle biopsy for pancreatic masses, gastrointestinal subepithelial lesions, and lymph nodes
Background: Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is a well-established diagnostic tool to obtain tissue from solid pancreatic masses, gastrointestinal subepithelial lesions, lymph nodes, liver as well as other neighboring organs. EUS-TA has proven to have a major clinical impact in diagnosis and staging, decreasing the need for invasive diagnostic procedures, such as thoracoscopy, mediastinoscopy, laparoscopy and open surgery.
Cell therapy with autologous mesenchymal stem cells for premature baby with neonatal sepsis and bronchopulmonary dysplasia: Case report
Bronchopulmonary dysplasia (BPD) remains the most common disease in premature newborns, associated with immature lung injury under the influence of supplemental oxygen and mechanical ventilation. “Classical BPD” is observed in premature newborns who have not received surfactant treatments. It is characterized by pulmonary fibrosis due to oxygen toxicity and volumetric/barometric trauma caused by mechanical ventilation. A new or "mild" form of BPD is observed in children born at 29 weeks of gestation, and is characterized by disordered pulmonary development due to prematurity.
Commentary to: Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response
The major message of this manuscript is that miR-93-5p is a potential therapeutic target in sepsis through the regulation of both innate and adaptive immunity, with possibly a greater benefit for elderly patients than for young patients.
Towards personalized care: Unraveling the genomic and molecular basis of sepsis-induced respiratory complications
Sepsis, a life-threatening syndrome characterized by organ dysfunction, is a global health concern with alarmingly high morbidity and mortality rates [1]. In understanding sepsis, particularly its association with respiratory complications, we gain valuable insights into improving patient outcomes [2].